2020 IPO

SQZ Biotech Stock

SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies.

Sign up today and learn more about SQZ Biotech Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Founded

2013

Notable Investors

NanoDimension

Headquarters

Watertown MA, US

Total Funding

$101M

About SQZ Biotech Stock

SQZ Biotechnologies is a Massachusetts-based, privately held company developing cellular therapies for multiple indications using the proprietary CellSqueeze® technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.

Investors

Funding History

April 2014$15K
October 2014$100K
June 2015$5.0M
September 2016$16.0M
December 2016$8.3M
August 2018$72.0M

Management

Director of Strategic Scientific Partnerships

Jonathan Gilbert

CEO

Armon Sharei

Chief Scientific Officer

Howard Bernstein

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo